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S U M M A R Y
Chronic hepatitis C virus (HCV) infection is a complex, multi-organ disorder, not just limited to the liver.
Mixed cryoglobulinemia (MC) type 2 is a common extrahepatic complication, in which immunoglobulin
complexes deposit in vascular endothelium. This in turn creates a diffuse inﬂammatory reaction, leading
to a variety of disorders involving multiple systems. We report the rare case of a patient with
cryoglobulinemia, cutaneous vasculitis, membroproliferative glomerulonephritis, and B cell lymphoma
with a variant t(6;10) translocation in the setting of an untreated, chronic HCV infection. This case
highlights the challenge associated with diagnosing and managing such a complex presentation.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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The hepatitis C virus (HCV) is an enveloped, single-stranded,
positive-sense RNA virus whose primary target organ is the liver.
Unfortunately, patients are prone to develop chronic infection with
signiﬁcant morbidity and mortality, leading to cirrhosis and liver
cancer.1
More recently, the pathogenesis of HCV infection has become
increasingly linked to multiple organs, not just limited to the liver.1
The extrahepatic manifestations are associated with an increased
risk of cryoglobulinemia seen with chronic HCV infection.
Speciﬁcally, mixed cryoglobulinemia (MC) type 2 has a wide
prevalence in those positive for HCV.1,2 These immunoglobulin
complexes have a tendency to precipitate in vascular endothelium
causing vasculitis leading to multiple organ damage, including
damage to the cutaneous, renal, and hematopoietic systems.1
We report the case of a patient with an untreated chronic HCV
infection with extensive extrahepatic manifestations. The complex
nature of his condition was not adequately addressed initially, as it
was masked by initial diagnoses of anemia and cellulitis. This case
highlights the difﬁculty in early identiﬁcation and management of
extrahepatic complications in chronic HCV infection.* Corresponding author.
E-mail address: anmeilli@gmail.com (A. Meillier).
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A 61-year-old Caucasian male prisoner with a past medical
history of chronic HCV infection (treatment-naı¨ve), liver cirrhosis,
and chronic kidney disease had recently been discharged from
another local hospital after receiving a blood transfusion for anemia
and a course of daptomycin for cellulitis of the lower extremities.
At8 days afterdischarge, the patient presentedto our facility with
progressive shortness of breath and orthopnea over 1 week. In the
emergency department, the patient appeared pale and tachypneic
with a blood pressure (BP) of 184/102 mmHg, pulse rate of 121/min,
andrespiratoryrateof24/min.Hisoxygensaturation(SpO2)was99%.
Signiﬁcant ﬁndings on physical examination included bibasilar
decreased breath sounds with trace pitting edema of the lower
extremities. On skin examination, an approximately 10  10-cm2,
non-painful, purpuric plaque with central ulceration was noted on
the mid shin bilaterally (Figure 1). As per patient report, these lesions
had developed after he fell and suffered signiﬁcant abrasions to the
area. The lesions were treated as cellulitis by the prison medical team
and the local hospital with oral antibiotics and intravenous
daptomycin, respectively, without improvement. The initial labora-
toryevaluationwassigniﬁcantforhemoglobinof7.5 g/dl (baselineof
9.3 g/dl) and creatinine of 2.4 mg/dl at baseline. Urinalysis was
remarkable for protein 100 mg/dl, 63 red blood cells/high-power
ﬁeld (HPF), 13 white blood cells/HPF, and hyaline casts of 5–10/low-
power ﬁeld. A random quantitative urine protein was 224 mg/dl.
The patient was initially started on nitroglycerin drip, furose-
mide, and hydralazine to treat the hypertensive emergency. His
blood pressure responded appropriately; systolic BP decreasedociety for Infectious Diseases. Open access under CC BY-NC-SA license.
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was admitted to the medicine service for observation and further
workup. Over the course of 14 days, his BP was controlled
aggressively with multiple oral medications including diltiazem,
hydralazine, metoprolol, and clonidine.
The anemia was initially treated with a transfusion of packed
red blood cells. Despite the transfusion, the hemoglobin level
remained low without any active signs of bleeding. Anemia
workup yielded a mean corpuscular volume of 91.0 ﬂ, serum iron
of 54 mg/ml, total iron-binding capacity of 157 mg/dl, and ferritin
of 766 ng/ml, suggesting anemia of chronic disease. On the
peripheral smear, cryoglobulin (CG) precipitates and abnormal-
appearing white blood cells suspicious for hairy cells were noted
incidentally, which prompted further investigations. The CG test
was positive with a cryocrit level of 5.0% and revealed MC type 2
with IgG and IgM-k predominance. Serum C4 levels were also low
at <2 mg/dl (reference range 20–25 mg/dl). A bone marrow biopsy
revealed B-cell non-Hodgkin lymphoma (B-NHL), with cytogenetic
analysis showing translocation between the long arms of
chromosomes 6 and 10, t(6;10).
Based on these ﬁndings, HCV-induced renal disease was highly
suspected. A percutaneous renal biopsy was subsequently
performed, with histopathology consistent with hepatitis C-
associated diffuse membroproliferative glomerulonephritis
(MPGN). At this time, it was concluded that the skin pathology
seen in this patient was most consistent with MC-induced
vasculitis, rather than chronic cellulitis. Furthermore, magnetic
resonance imaging (MRI) was negative for any evidence of
osteomyelitis. Subsequently, intravenous antibiotic therapy was
discontinued. Instead, the patient received three rounds of
plasmapheresis. Upon discharge, a regimen of methylprednisolone
sodium succinate 100 mg daily and rituximab 700 mg weekly was
prescribed with close outpatient follow-up. The patient completed
4 weeks of rituximab with improvement in blood counts and lower
extremity ulcers. On the initial visit, the hepatology department
chose to postpone HCV therapy until a later time, due to the history
of renal failure and B cell lymphoma.
3. Discussion
HCV infection mainly targets the liver, causing hepatitis,
cirrhosis, and hepatocellular carcinoma.3 In the last two decades,
we have begun to appreciate that chronic HCV infection is also an
extrahepatic, multi-system disorder. The mechanism by which
HCV infection induces extrahepatic manifestations is poorly
understood. Unlike its direct cytopathic effects on the liver, it isthought that HCV infection upregulates the humoral immune
system. This, in turn, activates a cascade of events, ultimately
leading to extrahepatic injury.1
There are three types of cryoglobulinemia.4 MC type 2 is the
most common extrahepatic manifestation of chronic HCV infec-
tion. It is present in more than 50% of patients with the chronic
infection.1 It has been shown that HCV infection leads to antigenic
stimulation of B cells, increasing the production of monoclonal and
polyclonal immunoglobulins, including molecules with rheuma-
toid factor (RF) activity.4 In 20–30% of HCV-infected patients, RFs
form CGs, immune complexes that reversibly precipitate at cold
temperatures.2 These complexes deposit in the walls of mainly
small vessel arteries to initiate the complement cascade and wreak
havoc in multiple organs.2
Cryoglobulinemic vasculitis is most evident on the skin as
palpable purpura, seen in virtually all patients with cryoglobuli-
nemia.2 This condition may resolve spontaneously, leaving behind
post-vasculitic skin discoloration formed from hemosiderin
deposits.2 In some patients, chronic ulceration may be predomi-
nant.2 Histologically, HCV-related protein is seen in cutaneous
small blood vessels, along with IgM and/or IgG complexes at the
intraluminal site of vascular damage. This demonstrates the direct
role of HCV infection in cryoglobulinemic vasculitis.2 The kidneys
are also affected by similar deposition of immunoglobulins and
HCV core protein in the glomeruli capillary walls.2 MPGN type 1 is
a common manifestation of HCV infection; the CGs in the vascular
endothelium activate the complement cascade with subsequent
uncontrolled activation of C3 convertase, leading to spontaneous
MPGN.4,5
Several key epidemiological studies have revealed a strong
association between HCV and B-NHL.3 However, the mechanism
by which HCV infection leads to B-NHL is still poorly understood.
Studies have suggested the direct infection of hematopoietic cells,
which leads to malignant lymphoproliferation.3 However, there
exists no in vivo model supporting this proposed mechanism.
There appears to be a gap from lymphoproliferation to malignan-
cy.3 This implies a malignant transforming event, such as gene
rearrangement. In one study, translocation t(14;18) has been
shown to be strongly associated with chronic HCV infection,
putting forward a more complete model in which HCV infection
initiates a clonal B cell expansion, which is vulnerable to malignant
transformation through yet another mechanism.3 The current
patient’s t(6;10) translocation indicated clonally proliferative
abnormal cells with no clear association of chronic HCV infection
initiating the malignant transforming event.
Chronic HCV infection is a complex, multi-organ disorder. In our
patient, multiple extrahepatic manifestations were present,
highlighting the challenge of diagnosing and managing this
condition. His early cutaneous involvement was presumed as
cellulitis by multiple providers, exposing the patient to unneces-
sary intravenous antibiotics. Suspicion should remain high for this
unique presentation, especially when ambiguous symptoms arise
in a patient with chronic HCV infection.
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